Julie So-Young Kim - 18 Mar 2026 Form 3 Insider Report for TAKEDA PHARMACEUTICAL CO LTD (TAK)

Role
CEO - Elect
Signature
/s/ Max Heuer, by power of attorney, for Julie Kim
Issuer symbol
TAK
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 06:19:47 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kim Julie So-Young CEO - Elect 500 KENDALL STREET, CAMBRIDGE /s/ Max Heuer, by power of attorney, for Julie Kim 18 Mar 2026 0001977732

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TAK American Depositary Shares 324,729 18 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 150,956 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (70,110 shares), July 1, 2027 (52,218 shares) and July 1, 2028 (28,628 shares).

Remarks:

Exhibit 24 Power of Attorney